Susquehanna International Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,500
Closed -$21K 14665
2021
Q4
$21K Sell
18,500
-119,200
-87% -$243K ﹤0.01% 12824
2021
Q3
$344K Buy
+137,700
New +$382K ﹤0.01% 10285
2021
Q2
Sell
-24,200
Closed -$85K 13770
2021
Q1
$85K Sell
24,200
-67,400
-74% -$375K ﹤0.01% 11913
2020
Q4
$435K Sell
91,600
-71,400
-44% -$369K ﹤0.01% 8576
2020
Q3
$792K Sell
163,000
-33,300
-17% -$158K ﹤0.01% 6691
2020
Q2
$638K Buy
+196,300
New +$1.86M ﹤0.01% 6848

Other funds holding CEMI

Susquehanna International Group's CEMI Position: Q1 2023 in Review

Susquehanna International Group sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2023, closing a stake of 56,869 shares — an estimated $12.5K sold.

Susquehanna International Group first reported a position in CEMI in Q2 2020 and held it in 10 quarters. The position peaked at $1.03M in Q4 2020. 30 funds tracked by Wall St. Rank hold CEMI as of Q1 2023.

  • Susquehanna International Group reported no remaining Chembio diagnostics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 56,869 Chembio diagnostics, Inc. shares in Q1 2023, an estimated $12.5K.
  • Susquehanna International Group first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 10 quarters.
  • Susquehanna International Group's Chembio diagnostics, Inc. position peaked at $1.03M in Q4 2020.
  • 30 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.